 |
|
Year
2007
|
|
|
|
|
|
“Finasteride Can Be Applied Without Great Concern for Sexual Dysfunction” Say Researchers
July 27, 2007
According to the authors of a novel study, men now can use finasteride devoid of any fret for sexual dysfunction. A proven therapy for the prevention of prostate cancer, the drug is often neglected by most men because of the probability of sexual dysfunction. The study was conducted by the Southwest Oncology Group over17, 000 men aged 55 or above for seven years.
The results of this study were published in the July 4 Journal of the National Cancer Institute. The findings have dispelled a major concern of the most men in relation to sexual dysfunction which is dogmatically associated with the drug till now.
Finasteride is an FDA-approved preparation to cure benign prostatic hyperplasia, but it is still not approved for the deterrence or reduction of prostate cancer. Due to its association with sexual dysfunction, physicians usually notify patients about the odds of sexual dysfunction while the intake of the drug.
The availability of large samples and elongated time for follow-up enabled researchers to better scrutinize whether or not finasteride negatively affects men’s sexual function and if it is, then whether such effect was long-lasting or for a short stint, said Carol Moinpour of the Fred Hutchison Cancer Research Center in Seattle and the study’s lead author. She synchronizes quality-of-life studies for the Southwest Oncology Group, which is the nation’s largest National Cancer Institute-funded clinical trials network.
The study took shape out of the Prostate Cancer Prevention Trial, a large double-blind National Cancer Institute-funded study which revealed that finasteride, a medicine which comes handy for the proliferation of prostate gland cells, is also effectual for the prevention of prostate cancer in men aged 55 or above. Conducted by the Southwest Oncology Group over 18,000 men, the trial uncovered that the preparation might diminish a man’s risk of getting prostate cancer by nearly 25 percent.
During their study, researchers employed two surveys. One is broadly utilized sexual problems scale and the other is sexual activity scale, which was created by them. In addition, they also collected other data to incorporate some additional health factors affecting sexual function, including age, smoking status and medical conditions. They reviewed subjects thrice in the first year and then annually for next seven years.
In the conclusion, the authors advocated that finasteride can result modest or no sexual dysfunction in men making use of it. |
